⚕ GalenOps CRO console
← 704 (USA)

704-1025

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 704 (USA) (Dr. Tanaka) · consented 2013-09-27
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild ELECTROCARDIOGRAM ST SEGMENT DEPRESSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-11 (study day 15.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild ELECTROCARDIOGRAM ST SEGMENT DEPRESSION — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 15.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate PALPITATIONS — outcome: RECOVERED/RESOLVED; onset 2013-09-28 (study day 2.0); relationship: REMOTE

moderate assessed 2026-08-18

Moderate VERTIGO — outcome: RECOVERED/RESOLVED; onset 2013-09-28 (study day 2.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild WOLFF-PARKINSON-WHITE SYNDROME — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-25 (study day 29.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild WOLFF-PARKINSON-WHITE SYNDROME — outcome: RECOVERED/RESOLVED; onset 2013-10-25 (study day 29.0); relationship: POSSIBLE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.